학술논문
Pathway level alterations rather than mutations in single genes predict response to HER2-targeted therapies in the neo-ALTTO trial
Document Type
Article
Author
Source
In Annals of Oncology January 2017 28(1):128-135
Subject
Language
ISSN
0923-7534